← Back to headlines
Novo Nordisk CEO Resets Expectations for Wegovy Growth
The CEO of Novo Nordisk has adjusted expectations for the explosive growth of its popular weight-loss drug, Wegovy.
6 Aug, 22:03 — 6 Aug, 22:03
Sources
Showing 1 of 1 sources
The CEO of Novo Nordisk has adjusted expectations for the explosive growth of its popular weight-loss drug, Wegovy.